» Articles » PMID: 28366409

Demographic, Lifestyle, and Other Factors in Relation to Antimüllerian Hormone Levels in Mostly Late Premenopausal Women

Abstract

Objective: To identify reproductive, lifestyle, hormonal, and other correlates of circulating antimüllerian hormone (AMH) concentrations in mostly late premenopausal women.

Design: Cross-sectional study.

Setting: Not applicable.

Patient(s): A total of 671 premenopausal women not known to have cancer.

Intervention(s): None.

Main Outcome Measure(s): Concentrations of AMH were measured in a single laboratory using the picoAMH ELISA. Multivariable-adjusted median (and interquartile range) AMH concentrations were calculated using quantile regression for several potential correlates.

Result(s): Older women had significantly lower AMH concentrations (≥40 [n = 444] vs. <35 years [n = 64], multivariable-adjusted median 0.73 ng/mL vs. 2.52 ng/mL). Concentrations of AMH were also significantly lower among women with earlier age at menarche (<12 [n = 96] vs. ≥14 years [n = 200]: 0.90 ng/mL vs. 1.12 ng/mL) and among current users of oral contraceptives (n = 27) compared with never or former users (n = 468) (0.36 ng/mL vs. 1.15 ng/mL). Race, body mass index, education, height, smoking status, parity, and menstrual cycle phase were not significantly associated with AMH concentrations. There were no significant associations between AMH concentrations and androgen or sex hormone-binding globulin concentrations or with factors related to blood collection (e.g., sample type, time, season, and year of blood collection).

Conclusion(s): Among premenopausal women, lower AMH concentrations are associated with older age, a younger age at menarche, and currently using oral contraceptives, suggesting these factors are related to a lower number or decreased secretory activity of ovarian follicles.

Citing Articles

Age at menarche and risk of ovarian hyperstimulation syndrome in women undergoing IVF/ICSI cycles: a retrospective cohort study.

Wang Q, Tang X, Lv X, Meng X, Geng L, Zhong Z BMJ Open. 2024; 14(2):e076867.

PMID: 38365296 PMC: 10875511. DOI: 10.1136/bmjopen-2023-076867.


Follicle development and its prediction in patients with primary ovarian insufficiency: Possible treatments and markers to maximize the ability to conceive with residual follicles.

Osuka S, Kasahara Y, Iyoshi S, Sonehara R, Myake N, Muraoka A Reprod Med Biol. 2023; 22(1):e12556.

PMID: 38144239 PMC: 10746865. DOI: 10.1002/rmb2.12556.


Associations of reproductive and breastfeeding history with anti-Müllerian hormone concentration among African-American women of reproductive age.

Komorowski A, Jiang C, Berrocal V, Neff L, Wise L, Harmon Q Reprod Biomed Online. 2023; 47(5):103323.

PMID: 37751677 PMC: 10828113. DOI: 10.1016/j.rbmo.2023.103323.


Geographical Diversity in the Age Specific Anti Müllerian Hormone Levels in Infertile Women: A Hospital based Cohort Study.

Jaffar M, Ahmad S, Monica , Ashraf M, Shaik S, Asif M J Hum Reprod Sci. 2023; 16(1):29-35.

PMID: 37305773 PMC: 10256946. DOI: 10.4103/jhrs.jhrs_163_22.


Association between cigarette smoking and ovarian reserve among women seeking fertility care.

Oladipupo I, Ali T, Hein D, Pagidas K, Bohler H, Doll M PLoS One. 2022; 17(12):e0278998.

PMID: 36512605 PMC: 9746951. DOI: 10.1371/journal.pone.0278998.


References
1.
McSorley M, Alberg A, Allen D, Allen N, Brinton L, Dorgan J . Prediagnostic circulating follicle stimulating hormone concentrations and ovarian cancer risk. Int J Cancer. 2009; 125(3):674-9. PMC: 2706295. DOI: 10.1002/ijc.24406. View

2.
Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S . Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab. 2003; 88(12):5957-62. DOI: 10.1210/jc.2003-030727. View

3.
van Rooij I, Tonkelaar I, Broekmans F, Looman C, Scheffer G, de Jong F . Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause. 2004; 11(6 Pt 1):601-6. DOI: 10.1097/01.gme.0000123642.76105.6e. View

4.
La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio A . Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2009; 16(2):113-30. DOI: 10.1093/humupd/dmp036. View

5.
Hallmans G, Agren A, Johansson G, Johansson A, Stegmayr B, Jansson J . Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort - evaluation of risk factors and their interactions. Scand J Public Health Suppl. 2003; 61:18-24. DOI: 10.1080/14034950310001432. View